Calibr, A Division Of Scripps Research

This early-stage study tested the safety of a new drug called PDM608 in 64 healthy adults. The goal was to see if the drug is safe and how the body processes it. This is a first step before testing the drug in people with Parkinson's disease.

This study followed 16 people who had already received a special immune cell treatment (CLBR001 CAR-T) for several types of blood cancers like lymphoma and leukemia. The main goal was to watch for any new or long-lasting side effects over time. Researchers also checked if the can…